Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

N/ARecruitingNCT00616317

University of California, Davis50 enrolled

Overview

The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Antiphospholipid Syndrome

Eligibility

Sex: ALLMin age: 1 MinuteMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years of age or younger at the onset of disease * Presence of Vascular Thrombosis * UC Davis patient * Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma Exclusion Criteria: * Infants born to mothers with APS * Infants with congenital thrombophilia

Locations (1)

UC Davis Medical Center

Sacramento, California, United States

RECRUITING

Outcomes

Primary Outcomes

Long term survival

Time frame: 10 year

Central Contacts

Lavjay Butani

CONTACT

(916) 734-8118

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.